Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2000
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054892A1 Azole peptidomimetics as thrombin receptor antagonists
11/29/2000EP1054890A1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054885A2 Benzisoxazole derivatives having d4-antagonistic activity
11/29/2000EP1054884A1 Benzofuran-4-carboxamides and their therapeutic use
11/29/2000EP1054882A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
11/29/2000EP1054881A1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054876A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054870A1 Heterocyclic topoisomerase poisons
11/29/2000EP1054869A1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors
11/29/2000EP1054868A1 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
11/29/2000EP1054865A1 Farnesyl transferase inhibitors
11/29/2000EP1054863A2 2-aminoquinoline derivatives having d4-agonistic activity
11/29/2000EP1054858A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
11/29/2000EP1054857A1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/29/2000EP1054693A1 Inhibitors of complement activation
11/29/2000EP1054692A2 Antibodies against human cd40
11/29/2000EP1054690A2 Hapten-modified tumor cell membranes and their use
11/29/2000EP1054687A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas
11/29/2000EP1054684A1 Method of promoting neuronal cell proliferation and differentiation
11/29/2000EP1054673A1 Benzoxazine compounds for enhancing synaptic response
11/29/2000EP1054669A2 Use of thiadiazolo[4,3-a]pyridine derivatives
11/29/2000EP1054667A1 Bicyclic pyrrole compounds, pharmaceutical compositions containing them and their use as antiinflammatory and immunomodulating agents
11/29/2000EP1054633A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
11/29/2000EP0863905B1 imidazole lipoxygenase inhibitors
11/29/2000EP0809484B1 Cosmetic or pharmaceutical, particularly dermatological, composition containing a bertholletia extract
11/29/2000EP0784753B1 Axial flow valve system in combination with a linera compressor
11/29/2000EP0655055B1 Tachykinin antagonists
11/29/2000EP0555205B1 Dna encoding a growth factor specific for epithelial cells
11/29/2000CN1275132A Treatmet of obesity
11/29/2000CN1275127A Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use
11/29/2000CN1275123A Prostaglandin agonists and their use to treat bone disorders
11/29/2000CN1275078A Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament for treating non-allergic ophthalmic inflammatory disorders
11/29/2000CN1275052A Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
11/29/2000CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/29/2000CN1058991C Hematopoietic facilitatory cells
11/29/2000CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture
11/29/2000CN1058967C Novel pyridine compounds, processes for their preparation and pharmaceutical compositions thereof
11/29/2000CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them
11/29/2000CN1058901C Slimming tea and its preparation
11/29/2000CN1058898C Specific quick catalytic injection
11/29/2000CN1058885C Drug-stopping addiction-removing capsule
11/29/2000CN1058877C Aconite granular preparation and its preparation method
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153651 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/28/2000US6153640 For treating depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety
11/28/2000US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
11/28/2000US6153625 For treatment of disorders in which involvement of serotoninergic system has been demonstrated, as in psychiartic disorders such as depression, anxiety, panic attack, schizophrenia, aggression, impulsive disorders
11/28/2000US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
11/28/2000US6153620 Opiate receptor antagonist modulates movement disorder
11/28/2000US6153614 Piperazinyl pyrimidine dione compounds selective for adrenoceptors
11/28/2000US6153604 Treating disease of nervous system in which pathophysiology of disorder involves excessive excitation of nerve cells by agonists of nmda receptors, comprising administering to guanidine derivative
11/28/2000US6153591 Protecting nervous system following focal ischemia and global ischemia; alzheimer's disease, huntington's disease, prion diseases, parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, alopacia, rheumatoid arthritis
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153228 Propolis extract
11/28/2000US6153227 Reducing the odor by soaking propolis in a hydrophilic solvent, e.g., methanol, to effect extraction followed by treating the liquid layer with an anion exchange resin; without attenuating the inherent biological activities
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/28/2000CA2164303C Aromatic acetylcholinesterase inhibitors
11/28/2000CA2085037C Stabilized pharmaceutical compositions comprising an hmg-coa reductase inhibitor compound
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070071A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070021A2 Differentiated human embryoid cells and a method for producing them
11/23/2000WO2000070017A2 Methods using of fab i and compounds modulating fab i activity
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000WO2000069898A2 Molecular interactions in allergy cells
11/23/2000WO2000069897A2 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes
11/23/2000WO2000069896A2 Molecular interactions in haematopoietic cells
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069868A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof
11/23/2000WO2000069855A2 Furanone derivatives as inhibitors of cathepsin s
11/23/2000WO2000069848A1 Compounds having cytokine inhibitory activity
11/23/2000WO2000069847A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
11/23/2000WO2000069846A1 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
11/23/2000WO2000069842A1 Benzofuranylsulfonates
11/23/2000WO2000069834A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069833A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
11/23/2000WO2000069832A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants
11/23/2000WO2000069831A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/23/2000WO2000069826A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
11/23/2000WO2000069824A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000WO2000069823A1 Ion channel modulating agents
11/23/2000WO2000069821A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000WO2000069820A1 Cyclic amine derivatives and their uses
11/23/2000WO2000069819A1 Hydroxamic acid derivatives as matrix metalloprotease inhibitors
11/23/2000WO2000069812A1 Novel hydroxamic acid derivatives
1 ... 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 ... 1564